New drug targets pancreatic cancer before surgery
NCT ID NCT07645651
First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 3 times
Summary
This early-stage trial tests a drug called samuraciclib in 15 people with localized pancreatic cancer that can be surgically removed. Participants will take the drug for about two weeks before their planned surgery. Researchers will check safety and look for changes in tumor cells to see if the drug hits its target. The goal is to gather initial evidence for a possible future treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- samuraciclib (a CDK7 inhibitor drug)
- What this could lead to
- If successful, this could point toward a new treatment option for localized pancreatic cancer.
- What could go wrong
- This is a very early Phase 1b trial with only 15 people. It is designed mainly to check safety and biological activity, not to prove the drug works. Many early-stage cancer drugs do not advance to larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene test may guide smarter chemo for pancreatic cancer
- Could a Decades-Old parasite drug help fight pancreatic cancer?
- Could a special MRI help doctors better treat pancreatic cancer?
- Triple attack on pancreatic cancer: radiotherapy, chemo, and immunotherapy aim to make tumors removable
- Triple threat against pancreatic cancer: radiation, immunotherapy, and chemotherapy combined
- Experimental combo therapy targets Hard-to-Treat pancreatic cancer